Home › Kanser ng Endometrium › Rhode Island › Providence

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Providence, RI

14 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Providence (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Nagre-recruitPhase 3

Rhode Island Hospital, Providence
Women and Infants Hospital, Providence

Edad 18 pataas · Kababaihan · Na-update Okt 5, 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2

Women and Infants Hospital, Providence
Roger Williams Medical Center, Providence

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Nagre-recruitPhase 1/2

Research Site, Providence

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05797168

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Nagre-recruitPhase 1

Women and Infants Hospital, Providence

Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT05950464

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Nagre-recruitPhase 2

Women and Infants Hospital, Providence

Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Nagre-recruitPhase 2

Women and Infants Hospital, Providence

Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT05640999

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Nagre-recruitPhase 3

Women & Infants Hospital ( Site 5003), Providence

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06952504

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Nagre-recruitPhase 1

Women & Infants Hospital of Rhode Island, Providence

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06515613

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Nagre-recruitPhase 3

Research Site, Providence

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06989112

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Nagre-recruitPhase 2

Women & Infants Hospital, Providence

Edad 18 pataas · Kababaihan · Na-update Ago 21, 2026 · NCT05548296

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2

Women and Infants Hospital of Rhode Island, Providence

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Nagre-recruitPhase 2

Women & Infants Hospital, Providence

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2025 · NCT05997017

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Nagre-recruitPhase 1/2

Women & Infants Hospital, Providence

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2025 · NCT05902988

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Providence

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod

Iba pang pag-aaral sa Providence

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.